Bronchopulmonary dysplasia and erythropoietin

Neonatology

Volumn 103, Issue 2, 2013, Pages 123-

  Meyer, M P ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

HUMAN; INFANT DISEASE; LETTER; LUNG DYSPLASIA; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA; TREATMENT DURATION; ASSISTED VENTILATION;

BRONCHOPULMONARY DYSPLASIA; ERYTHROPOIETIN; FEMALE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, EXTREMELY PREMATURE; MALE;

EID: 84873737159     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000343977     Document Type: Letter

References (3)

1. Rayjada N, Barton L, Chan LS, Plasencia S, Biniwale M, Bui KC: Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study. Neonatology 2012; 102: 287-292.
2. Aher SM, Ohlsson A: Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; 3: CD004868.
3. Ohlsson A, Aher SM: Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; 3: CD004863.